Amkay Products IPO is a book build issue of ₹12.61 crores. The issue is entirely a fresh issue of 0.23 crore shares of ₹12.61 crore.
Amkay Products IPO bidding started from Apr 30, 2024 and ended on May 3, 2024. The allotment for Amkay Products IPO was finalized on May 6, 2024. The shares got listed on BSE SME on May 8, 2024.
Amkay Products IPO price band is set at ₹55.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an retail is ₹1,04,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,20,000.
Hem Securities Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Hem Finlease Pvt.Ltd..
Refer to Amkay Products IPO RHP for detailed Information.
IPO Date | April 30, 2024 to May 3, 2024 |
Listing Date | May 8, 2024 |
Face Value | ₹10 per share |
Issue Price Band | ₹52 to ₹55 per share |
Issue Price Final | ₹55 per share |
Lot Size | 2,000 Shares |
Sale Type | Fresh Capital |
Total Issue Size | 22,92,000 shares (aggregating up to ₹12.61 Cr) |
Reserved for Market Maker | 1,20,000 shares Hem Finlease Pvt.Ltd. (aggregating up to ₹0.6600 Cr) |
Net Offered to Public | 21,72,000 shares (aggregating up to ₹11.95 Cr) |
Issue Type | Bookbuilding IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 63,63,640 shares |
Share Holding Post Issue | 86,55,640 shares |
Amkay Products IPO offers total 22,92,000 shares. Out of which 10,84,000 (47.29%) allocated to QIB, 4,34,000 (18.94%) allocated to QIB, 3,26,000 (14.22%) allocated to NII, 7,62,000 (33.25%) allocated to RII and 6,50,000 (28.36%) allocated to Anchor investors.
Investor Category | Shares Offered |
---|---|
Market Maker Shares Offered | 1,20,000 (5.24%) |
QIB Shares Offered | 10,84,000 (47.29%) |
− Anchor Investor Shares Offered | 6,50,000 (28.36%) |
− QIB (Ex. Anchor) Shares Offered | 4,34,000 (18.94%) |
NII (HNI) Shares Offered | 3,26,000 (14.22%) |
Retail Shares Offered | 7,62,000 (33.25%) |
Total Shares Offered | 22,92,000 (100.00%) |
Amkay Products IPO raises ₹3.58 crore from anchor investors. Amkay Products IPO Anchor bid date is April 29, 2024. Amkay Products IPO Anchor Investors list
Bid Date | April 29, 2024 |
Shares Offered | 6,50,000 |
Anchor Portion Size (In Cr.) | 3.58 |
Anchor lock-in period end date for 50% shares (30 Days) | June 5, 2024 |
Anchor lock-in period end date for remaining shares (90 Days) | August 4, 2024 |
Amkay Products IPO opens on April 30, 2024, and closes on May 3, 2024.
IPO Open Date | Tue, Apr 30, 2024 |
IPO Close Date | Fri, May 3, 2024 |
Tentative Allotment | Mon, May 6, 2024 |
Initiation of Refunds | Tue, May 7, 2024 |
Credit of Shares to Demat | Tue, May 7, 2024 |
Tentative Listing Date | Wed, May 8, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on Fri, May 3, 2024 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 2,000 | ₹1,10,000 |
Retail (Max) | 1 | 2,000 | ₹1,10,000 |
HNI (Min) | 2 | 4,000 | ₹2,20,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in October 2007, Amkay Products Limited is a company that produces and sells a wide range of healthcare products including medical devices, disposables, and other essential items such as face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, and more. Their products are used by healthcare centers, hospitals/clinics, nursing homes, and other such facilities across India.
The company manufactures and markets products such as diapers, plastic gloves, and suction machines.
The company offers over 30 healthcare products, including medical devices for respiratory diseases, surgical disposables, home healthcare products, and others. We manufacture 20 products and brand/trade 10 others.
The manufacturing facility, which occupies an area of about 26000 sq. ft., is fully equipped with machines, a testing lab, and other handling equipment to ensure a smooth process. The company is also accredited under the ISO 9001:2015 standard by QRO Certification LLP for its quality management system.
The company has two manufacturing unit situated in Thane, Maharashtra and a Wearhouse situated in Thane Maharastra.
As of December 31, 2023, the company has employed about 75 employees across different levels of the organization.
Amkay Products Limited's revenue decreased by -23.22% and profit after tax (PAT) rose by 2.94% between the financial year ending with March 31, 2023 and March 31, 2022.
Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
Assets | 1,887.52 | 1,563.77 | 1,580.64 | 1,393.47 |
Total Income | 2,385.56 | 2,825.05 | 3,679.45 | 4,071.74 |
Profit After Tax | 215.34 | 151.02 | 146.71 | 312.68 |
Net Worth | 986.96 | 771.62 | 620.60 | 473.90 |
Reserves and Surplus | 350.59 | 743.95 | 592.93 | 446.23 |
Total Borrowing | 476.22 | 469.98 | 433.59 | 136.54 |
Amount in ₹ Lakhs |
The market capitalization of Amkay Products IPO is ₹47.61 Cr.
KPI as of Tue, Dec 31, 2024.
KPI | Values |
---|---|
ROE | 24.49% |
ROCE | 21.54% |
Debt/Equity | 0.48 |
RoNW | 21.82% |
PAT Margin | 9.47% |
Price to Book Value | 3.55 |
Pre IPO | Post IPO | |
---|---|---|
EPS Rs | 2.37 | 3.32 |
P/E (x) | 23.18 | 16.58 |
The company intends to utilize the proceeds of the Issue to meet the following objectives:
[Dilip Davda] The company is in medical device segment, which is not only overcrowded, but also on the verge of saturation point. It’s a highly competitive and fragmented segment post covid. Based on FY24 annualized earnings, the issue is fully priced discounting all near term positives. Well-informed/cash surplus investors may park moderate funds for the medium to long term rewards. Read detail review...
Listing Date | May 8, 2024 |
BSE Script Code | 544169 |
NSE Symbol | |
ISIN | INE0QSB01016 |
Final Issue Price | ₹55 per share |
BSE Listing Group | M |
Price Details | BSE SME |
---|---|
Final Issue Price | ₹55.00 |
Open | ₹104.50 |
Low | ₹104.50 |
High | ₹109.72 |
Last Trade | ₹109.72 |
Amkay Products Ltd.
Bunglow No. 68, Rashmi Park,
CHS Ltd., Dhumal Nagar
Waliv Road, Vasai, Thane 401208
Thane, Maharashtra
Phone: +91-9152094440
Email: cs@amkayproducts.com
Website: http://www.amkayproducts.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Amkay Products IPO is a SME IPO of 22,92,000 equity shares of the face value of ₹10 aggregating up to ₹12.61 Crores. The issue is priced at ₹55 per share. The minimum order quantity is 2000.
The IPO opens on April 30, 2024, and closes on May 3, 2024.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Amkay Products IPO using UPI as a payment gateway. Zerodha customers can apply in Amkay Products IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Amkay Products IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Amkay Products IPO opens on April 30, 2024 and closes on May 3, 2024.
Amkay Products IPO lot size is 2000, and the minimum amount required for application is ₹1,10,000.
You can apply in Amkay Products IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Amkay Products IPO will be done on Monday, May 6, 2024, and the allotted shares will be credited to your demat account by Tuesday, May 7, 2024. Check the Amkay Products IPO allotment status.
The Amkay Products IPO listing date is on Wednesday, May 8, 2024.
Useful Articles